Form 4 for GILD Gilead Sciences
Accepted 2024-11-07 00:00:00 ET · period of report 2024-11-06 · accession 0001127602-24-026735 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-07 | 2024-11-06 | GILD | Parsey Merdad | Chief Medical Off | S - Sale+OE | $91.50 | -25.6K | 99.6K | -20% | -$2.34M |
| D | 2024-11-07 | 2024-11-06 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | $57.92 | +25.0K | 125.2K | +25% | +$1.45M |
| D | 2024-11-07 | 2024-11-06 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | $0.00 | -25.0K | 121.7K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-06 | S | D | 20,590 | $91.50 | 104,599 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-06 | S | D | 5,000 | $91.50 | 99,599 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-06 | M | A | 25,000 | $57.92 | 125,189 | D | — | — | |
| 4 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-11-06 | M | D | 25,000 | $0.00 | 121,670 | D | $57.92 · — to 2032-03-10 | 25,000 Common Stock | (F2) The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |